Literature DB >> 16931333

The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites.

Oleg E Akilov1, Sachiko Kosaka, Katie O'Riordan, Xiangzhi Song, Margaret Sherwood, Thomas J Flotte, James W Foley, Tayyaba Hasan.   

Abstract

Photodynamic therapy (PDT) is emerging as a potential therapeutic modality in the clinical management of cutaneous leishmaniasis (CL). In order to establish a rationale for effective PDT of CL, we investigated the impact of the molecular charge and structure of photosensitizers on the parasitic phototoxic response. Two photosensitizers from the benzophenoxazine family that bear an overall cationic charge and two anionic porphyrinoid molecules were evaluated. The photodynamic activity of the photosensitizers decreases in the following order: EtNBSe > EtNBS > BpD > PpIX. The studies suggest that compared to hydrophobic anionic photosensitizers, the hydrophilic cationic benzophenoxazine analogs provide high effectiveness of PDT possibly due to (1) their strong attraction to the negatively charged parasitic membrane, (2) their hydrophilicity, (3) their high singlet oxygen quantum yield, and (4) their efficacy in targeting intracellular organelles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931333     DOI: 10.1016/j.chembiol.2006.06.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  16 in total

1.  Structure-function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers.

Authors:  Daniela Vecchio; Brijesh Bhayana; Liyi Huang; Elisa Carrasco; Conor L Evans; Michael R Hamblin
Journal:  Eur J Med Chem       Date:  2014-02-01       Impact factor: 6.514

2.  Topical and Intradermal Efficacy of Photodynamic Therapy with Methylene Blue and Light-Emitting Diode in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Mônica Raquel Sbeghen; Evandra Maria Voltarelli; Tácito Graminha Campois; Elza Kimura; Sandra Mara Alessi Aristides; Luzmarina Hernandes; Wilker Caetano; Noboru Hioka; Maria Valdrinez Campana Lonardoni; Thaís Gomes Verzignassi Silveira
Journal:  J Lasers Med Sci       Date:  2015-06-28

3.  Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.

Authors:  Elena Latorre-Esteves; Oleg E Akilov; Prakash Rai; Stephen M Beverley; Tayyaba Hasan
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

Review 4.  Drug discovery of antimicrobial photosensitizers using animal models.

Authors:  Sulbha K Sharma; Tianhong Dai; Gitika B Kharkwal; Ying-Ying Huang; Liyi Huang; Vida J Bil De Arce; George P Tegos; Michael R Hamblin
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis.

Authors:  Viviana M Taylor; David L Cedeño; Diana L Muñoz; Marjorie A Jones; Timothy D Lash; Alexandra M Young; Manuel H Constantino; Nicholas Esposito; Iván D Vélez; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

Review 6.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

Review 7.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

8.  Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine.

Authors:  Sujoy Dutta; Benson G Ongarora; Hairong Li; Maria da Graca H Vicente; Bala K Kolli; Kwang Poo Chang
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

Review 9.  Photoantimicrobials-are we afraid of the light?

Authors:  Mark Wainwright; Tim Maisch; Santi Nonell; Kristjan Plaetzer; Adelaide Almeida; George P Tegos; Michael R Hamblin
Journal:  Lancet Infect Dis       Date:  2016-11-22       Impact factor: 25.071

10.  Visible-light-responsive ZnCuO nanoparticles: benign photodynamic killers of infectious protozoans.

Authors:  Akhtar Nadhman; Samina Nazir; Malik Ihsanullah Khan; Attiya Ayub; Bakhtiar Muhammad; Momin Khan; Dilawar Farhan Shams; Masoom Yasinzai
Journal:  Int J Nanomedicine       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.